Studies on Hyaluronic Acid and cancer

[Clinical value of combined detection with urinary bladder cancer antigen, Hyaluronic Acid and cytokeratin 20 in diagnosis of bladder cancer].
2008 Ai zheng = Aizheng = Chinese journal of cancer

Urinary Hyaluronic Acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
2000 The Journal of urology

Urinary Hyaluronic Acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
2000 The Journal of urology

Urinary Hyaluronic Acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
2000 The Journal of urology

Urinary Hyaluronic Acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
2000 The Journal of urology

Micropatterned surfaces to study Hyaluronic Acid interactions with cancer cells.
2010 Journal of visualized experiments : JoVE

Significance of Elevated Levels of Collagen Type IV and Hyaluronic Acid in Gastric Juice and Serum in Gastric cancer and Precancerous Lesion.
2011 Digestive diseases and sciences

Increased expression of Hyaluronic Acid binding protein 1 is correlated with poor prognosis in patients with breast cancer.
2009 Journal of surgical oncology

Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells.
2009 Biomaterials

Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
1997 Cancer research

Does the lectin Helix pomatia agglutinin bind to Hyaluronic Acid in breast and colon cancer?
1996 Acta histochemica

Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
1997 Cancer research

Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
1997 Cancer research

Does the lectin Helix pomatia agglutinin bind to Hyaluronic Acid in breast and colon cancer?
1996 Acta histochemica

Interaction between CD44 and Hyaluronic Acid regulates human prostate cancer development.
1998 The Journal of urology

Novel Hyaluronic Acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
2008 Biotechnology and bioengineering

Interaction between CD44 and Hyaluronic Acid regulates human prostate cancer development.
1998 The Journal of urology

Interaction between CD44 and Hyaluronic Acid regulates human prostate cancer development.
1998 The Journal of urology

Hyaluronic Acid as prognostic marker in resectable colorectal cancer.
2000 The British journal of surgery

Hyaluronic Acid as prognostic marker in resectable colorectal cancer.
2000 The British journal of surgery

Hyaluronic Acid as prognostic marker in resectable colorectal cancer.
2000 The British journal of surgery

Polycationic nanodrug covered with Hyaluronic Acid for treatment of P-glycoprotein overexpressing cancer cells.
2010 Biomacromolecules

Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.
2010 Cancer chemotherapy and pharmacology

Hyaluronic Acid as prognostic marker in resectable colorectal cancer.
2000 The British journal of surgery

Hyaluronic Acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
2008 Cancer research

Hyaluronic Acid butyric esters in cancer therapy.
2005 Anti-cancer drugs

Hyaluronic Acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line.
1999 International journal of cancer. Journal international du cancer

Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with Hyaluronic Acid and potentiates their malignant progression.
2004 The Journal of urology

HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
2006 Urologic oncology

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
2009 Oligonucleotides

Association of Hyaluronic Acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
2011 Cancer

Evaluation of the prognostic potential of Hyaluronic Acid and hyaluronidase (HYAL1) for prostate cancer.
2003 Cancer research

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

Antitumor activity of Hyaluronic Acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
2010 Cancer research

Lipoplexes targeting the CD44 Hyaluronic Acid receptor for efficient transfection of breast cancer cells.
2009 Molecular pharmaceutics

Transperineal injection of Hyaluronic Acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients.
2009 Brachytherapy

Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid.
2010 Biomaterials

Cancer cell specific targeting of nanogels from acetylated Hyaluronic Acid with low molecular weight.
2010 European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

[Inhibitory effect of hyaluronic acid, hyaluronidase and RGD on adhesion and invasion of human gastric cancer cell line SGC7901].
2004 Zhonghua zhong liu za zhi [Chinese journal of oncology]

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

Binding of ovarian cancer cells to immobilized hyaluronic acid.
1997 Glycoconjugate journal

Stromal and epithelial expression of tumor markers Hyaluronic Acid and HYAL1 hyaluronidase in prostate cancer.
2001 The Journal of biological chemistry

Hyaluronic Acid is a useful tool for intraoperative sentinel node detection in gastric cancer surgery.
2007 Surgery

Overexpression of the receptor for Hyaluronic Acid mediated motility is an independent adverse prognostic factor in colorectal cancer.
2006 Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
2004 International journal of cancer. Journal international du cancer

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
2000 Biomacromolecules

Nanostructured hyaluronic acid-based materials for active delivery to cancer.
2010 Expert opinion on drug delivery

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
2000 Biomacromolecules

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
2000 Biomacromolecules

A pilot human evaluation of a formulation of irinotecan and Hyaluronic Acid in 5-fluorouracil-refractory metastatic colorectal cancer patients.
2009 Chemotherapy

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
2000 Biomacromolecules

Transperineal injection of Hyaluronic Acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
2007 International journal of radiation oncology, biology, physics

Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases Hyaluronic Acid levels.
2001 Kidney international

Utility of Hyaluronic Acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
1997 Japanese journal of clinical oncology

Utility of Hyaluronic Acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
1997 Japanese journal of clinical oncology